 CTV News | Baxter's Alzheimer's disease drug fails in late-stage trial Reuters Tue May 7, 2013 4:59pm IST. May 7 (Reuters) - Baxter International Inc said a late-stage study of its experimental drug to treat Alzheimer's disease failed to reduce the decline of cognitive functions and preserve functional abilities. The trial showed that after ... Alzhiemer drug Gammagard fails to slow Alzheimer's disease in late stage trial Baxter drug fails to slow Alzheimer's in big study Baxter Announces Topline Results of Phase III Study of Immunoglobulin for ... |
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS